About Saga University Hospital
佐賀大学医学部附属病院は、佐賀県佐賀市の佐賀大学鍋島キャンパス内にある大学病院である。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Saga University Hospital
During the past decade, Saga University Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 7 clinical trials were completed, i.e. on
average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)
2011-12-01
2018-12-14
Completed
51
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
2016-09-01
2023-08-01
Active, not recruiting
539
A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Intermediate or High-risk Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (Post-PV MF), or Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
2020-10-12
2025-06-30
Recruiting
31
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)
2021-05-26
2025-06-01
Active, not recruiting
212
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
2021-05-27
2026-05-23
Recruiting
440
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
2021-02-25
2025-08-23
Recruiting
309
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
2022-06-23
2033-01-26
Recruiting
864
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saga University Hospital" #1 sponsor was "Galapagos NV" with 3 trials, followed by "Gilead Sciences" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Celgene"
with 2 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saga University Hospital"
#1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "University of the Ryukyus" with 2 trials as a collaborator, "Chukyo Hospital" with 1 trials as a collaborator and "Ebina General Hospital" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Saga University Hospital
According to Clinical.Site data, the most researched conditions in "Saga University Hospital" are
"Crohn's Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials) and "Alport Syndrome" (1 trials). Many other conditions were trialed in "Saga University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Saga University Hospital
Most popular intervention types in "Saga University Hospital" are "Drug" (22 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Filgotinib" (4 trials), "Atezolizumab" (2 trials), "BMS-986165" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Saga University Hospital
The vast majority of trials in "Saga University Hospital" are
27 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Saga University Hospital
Currently, there are NaN active trials in "Saga University Hospital".
undefined are not yet recruiting,
5 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 11 completed trials in Saga University Hospital,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Saga University Hospital, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 0 trials that are defined as “Not Applicable".